The level of anti-UCH-L1 antibodies was significantly higher in patients with MCD than in the control group and in other glomerulopathies - FSGS, membranous nephropathy, IgA nephropathy and membranoproliferative glomerulonephritis. Here, UCHL1 is linked to membranoproliferative glomerulonephritis.